妊娠と小児の健康に関するジャーナル

抽象的な

Anesthetic Neurotoxicity to the Fragile Young Brain: Where Do We Stand?

Sonia Duarte, Alexandra Saraiva and Humberto S Machado

There is no doubt of the benefits of anesthesia in children which has allowed surgical procedures to be performed in the youngest infants, alleviating of pain, anxiety and maintaining stable vital signs. We also believe that anesthesia has indirectly improved quality of life and in many cases accounted for the saving of many young lives. However, in view of conflicting evidence, it is imperative to invest in future studies, based on scrupulous methodology that can undoubtedly translate the association between anesthesia and adverse neurocognitive outcomes in children. But while more and better-designed studies are being conducted, we have the obligation to be judicious and adopt a protective strategy for our young patients. Although we think there is no evidence to postpone or cancel truly urgent surgeries in young children, it seems to be reasonable that at least on children with less that 6 months, but preferably up to 3 years of age, the decision of proceeding to surgery should count the matter of anesthesia-related neurotoxicity as a possible cost. When necessary, anesthesia and surgery should be kept to the minimum time possible. Also, the avoidance of the agents most implicated, as toxic in animal studies such as ketamine, isoflurane and nitrous oxide seems wise 41, 42. As millions of children can be affected worldwide by this yet to explain possible phenomenon there is urgent need and place for a great deal of translational research so we can finally understand the association between neurotoxicity to the young brain and anesthesia, thus devising mitigating strategies. As Albert Einstein would say, “If you always do what you always did, you will always get what you always got.”